HealthService24 Final Project Report

HealthService24 ProjectHealthService24 Project validation pilots showed that the introduction of a mobile health monitoring service is not disruptive with current work practices. It can easily co-exist with other formats of service delivery, in some cases supplementing them or, in other cases, replacing previous practices. This facilitated the integration, putting the end-users in command to decide on the most adequate pace.

Furthermore, economic benefits were observed in all pilots. This means that from a financial perspective, hospitals and other care organizations can save money with this approach, mainly due to early discharges and less emergency room admissions.

However, the willingness to review the way care is being delivered must be clearly present, as well as the acceptance of re-allocating some professional roles. This reflects one important lesson of the pilots: the process of incorporating the mobile monitoring solution is more of socio-technical nature. Technology alone is not enough - it requires the right perception and use by the users to drive a change. New approaches to treatment and follow-up of patients were adopted. This undoubtedly maximised the benefits that mobile monitoring systems brought about. This meant: (a) Normalisation of care pathways (appropriate use and frequency of the monitoring services), (b) Reallocation of professional roles, (c) Specific patient education on the disease.

This has to have a clinical sense (based on established guidelines) but also should not add extra costs that could make the whole design unfeasible.

A note on insurance companies: HealthService24 Project pilots showed a financial interest from the hospitals point of view in terms of cost savings. But there is also another side of it, namely reimbursement from the insurance companies. Insurance companies in general see the value in the approach, but:

  • Long term results are needed in order to build a case
  • Payers/Health insurers should be properly included in validation scenarios to secure health economic outcomes
  • Statistics available to the insurance companies only show "Diabetic patients" or "Cardiac Patients", but do not provide the detail to identify the patients that would benefit from such an approach.
  • The identification has to be done in collaboration with the doctors
  • There is no practice for telemedicine evaluation today. This make is difficult to introduce telemedicine solutions in a routine setting

A note on legislation: Up to today, there is a lack of a European Union wide framework:

  • Teleconsultation is still not reimbursed in a number of countries in some countries, e.g. the Netherlands, legislation is changing in favour of telemedicine
  • No legislation available on liability
  • Privacy and security of patient data
  • Reimbursement is dependent on the healthcare system in respective countries (some have a joint National Health System (e.g. UK), others are very diverse (e.g. Germany))

As long as this is the situation ruling, we see low opportunities for implementing the HealthService24 concept on a nation-wide or even European-wide scale. Still, hospitals in charge of their own profit and loss will see economic benefits.

Concluding remark: The HealthService24 concept improves the quality of life of the patient and provides a higher rate of empowerment. At the same time, it was possible for the professionals to provide better care and lower care costs (up to 38% savings on direct costs were achieved). Using the HealthService24 concept is not disruptive - rather, integration into existing systems and processes is possible and adds value. However, technology itself is not enough - a successful implementation is much more subject to organizational matters such as re-design of conventional care delivery, both concerning the hospitals as well as to the insurance policy and the legislative situation.

For further information, please visit or download:

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...